← Back to Search

Text Message Reminders for Flu Vaccination

N/A
Recruiting
Led By Brian P. Jenssen, MD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English-speaking
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to approximately 30 days post-text message
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if sending text message reminders can improve flu vaccination rates for children, whether they have a scheduled doctor's visit or not, at the Children's Hospital of Philadelphia Care Network. This

Who is the study for?
This trial is for patients within the Children's Hospital of Philadelphia Care Network during flu season. It aims to assess if text message reminders can increase flu vaccination rates, regardless of whether patients have a scheduled well child care visit.
What is being tested?
The intervention being studied is the use of text message reminders to encourage flu vaccinations. The study will compare vaccination rates among those who receive reminders versus those who do not.
What are the potential side effects?
Since this trial involves sending text message reminders and does not include medication or medical procedures, there are no direct side effects associated with the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to approximately 30 days post-text message
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to approximately 30 days post-text message for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The effectiveness of a text message reminder on influenza vaccine uptake
Secondary study objectives
The effectiveness of text message language within Cohort 1
The effectiveness of text message language within Cohort 2

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Experimental Treatment
Active Control
Group I: Cohort 2cExperimental Treatment1 Intervention
Patients within Cohort 2 do not have an upcoming well visit between September-December 2024, but completed their well visit between January 2023 through August 2024. Patients within Cohort 2b are those randomized to INTERVENTION MESSAGE #2 and will receive text message reminder (variation #4) about getting their flu shot this upcoming flu season.
Group II: Cohort 2bExperimental Treatment1 Intervention
Patients within Cohort 2 do not have an upcoming well visit between September-December 2024, but completed their well visit between January 2023 through August 2024. Patients within Cohort 2b are those randomized to INTERVENTION MESSAGE #1 and will receive text message reminder (variation #3) about getting their flu shot this upcoming flu season.
Group III: Cohort 1cExperimental Treatment1 Intervention
Patients within Cohort 1 have an upcoming well child visit between September-December 2024. Patients within Cohort 1c are those randomized to INTERVENTION MESSAGE #2 and will receive text message reminder (variation #2) about getting their flu shot at their upcoming visit.
Group IV: Cohort 1bExperimental Treatment1 Intervention
Patients within Cohort 1 have an upcoming well child visit between September-December 2024. Patients within Cohort 1b are those randomized to INTERVENTION MESSAGE #1 and will receive text message reminder (variation #1) about getting their flu shot at their upcoming visit.
Group V: Cohort 1aActive Control1 Intervention
Patients within Cohort 1 have an upcoming well child visit between September-December 2024. Patients within Cohort 1a are those randomized to CONTROL and will not receive a text message reminder about getting their flu shot at their upcoming visit.
Group VI: Cohort 2aActive Control1 Intervention
Patients within Cohort 2 do not have an upcoming well visit between September-December 2024, but completed their well visit between January 2023 through August 2024. Patients within Cohort 2a are those randomized to CONTROL and will not receive a text message reminder about getting their flu shot.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Text message reminder
2012
N/A
~880

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
731 Previous Clinical Trials
8,172,319 Total Patients Enrolled
Brian P. Jenssen, MDPrincipal InvestigatorChildren's Hospital of Philadelphia
1 Previous Clinical Trials
190 Total Patients Enrolled
~200000 spots leftby Dec 2025